Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injectable Manufacturing: SOP for Handling Hazardous Materials during Dispensing – V 2.0

Posted on By

Sterile Injectable Manufacturing: SOP for Handling Hazardous Materials during Dispensing – V 2.0

Standard Operating Procedure for Handling Hazardous Materials during Dispensing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/101/2025
Supersedes SOP/SIM/101/2022
Page No. Page 1 of 14
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

To provide a detailed and standardized procedure for the safe handling of hazardous materials during dispensing in sterile injectable manufacturing. This ensures product integrity, operator safety, and compliance with GMP, WHO, and ICH guidelines.

2. Scope

This SOP applies to all activities related to the dispensing of hazardous raw

materials, including toxic, flammable, corrosive, or reactive substances used in the preparation of sterile injectable products at the pharmaceutical facility.

3. Responsibilities

  • Dispensing Operator: Responsible for executing the procedure for hazardous material handling as per SOP.
  • Production Supervisor: Ensures all required materials, PPE, and documentation are available and checks adherence.
  • Quality Assurance (QA): Verifies documentation, cross-checks procedures, and audits compliance with SOP.
  • EHS Officer: Provides hazard information and ensures appropriate safety measures are implemented.
See also  Sterile Injectable Manufacturing: SOP for Visual Inspection of Injectable Products for Clarity - V 2.0

4. Accountability

The Head of Production is accountable for ensuring overall compliance with this SOP and the safe handling of hazardous materials during dispensing operations.

5. Procedure

5.1 Receiving and Preliminary Inspection

  1. Receive hazardous raw materials in designated receiving bays.
  2. Visually inspect containers for damage, tampering, or leakage.
  3. Ensure all containers are labeled with product name, batch number, expiry date, and hazard symbols.
  4. Transfer materials to the hazardous material storage area using appropriate transport trolleys and PPE.

5.2 Documentation and Verification

  1. Check the Certificate of Analysis (CoA) against material specifications.
  2. Verify batch numbers, quantity received, and labeling against purchase orders and delivery challans.
  3. Log all entries in the Material Dispensing Log (Annexure-1).

5.3 Dispensing and Handling of Materials

  1. Ensure differential pressure and HVAC systems in dispensing area are operational and compliant.
  2. Wear full PPE including gloves, face shield, chemical-resistant overalls, and respirator (if required).
  3. Place the container inside an appropriate dispensing booth or isolator for containment.
  4. Weigh the required quantity using a calibrated balance as per the batch manufacturing record (BMR).
  5. Use antistatic mats and grounding clamps if flammable materials are involved.
  6. Immediately close and reseal partially used containers, label them appropriately, and return to hazardous storage.
See also  Sterile Injectable Manufacturing: SOP for Intermediate Storage of Bulk Injectable Products - V 2.0

5.4 Labeling, Approval, and Release of Materials

  1. Affix “Dispensed” labels on each dispensed container with material name, weight, date, and initials.
  2. Allow QA to verify the dispensed quantity and label accuracy.
  3. QA releases material with a stamp and signature on Approval and Release Form (Annexure-3).

5.5 Documentation and Record-Keeping

  1. Document material code, batch number, quantity dispensed, and initials in the Dispensing Log.
  2. Attach a copy of CoA to each batch folder and retain in QA files.
  3. Submit copies of all documentation to Production and QA for archival as per documentation policy.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • PPE: Personal Protective Equipment
  • CoA: Certificate of Analysis
  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record
See also  Sterile Injectable Manufacturing: SOP for Batch Release of Injectable Products - V 2.0

7. Documents

  1. Material Dispensing Log – Annexure-1
  2. Certificate of Analysis (CoA) – Annexure-2
  3. Approval and Release Form – Annexure-3

8. References

  • WHO TRS 986 Annex 2 – GMP for Pharmaceutical Products
  • ICH Q9 – Quality Risk Management
  • OSHA Chemical Safety Guidelines

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Manufacturing Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Material Dispensing Log

Date Material Name Batch No. Qty Dispensed (g) Operator
18/06/2025 Sodium Metabisulfite SMB202506 250 Rajesh Kumar

Annexure-2: Certificate of Analysis (CoA)

Material Hydroxypropyl Beta-Cyclodextrin
Batch No. HBC-0618A
Test Performed LOD, Assay, Identification
Result Complies
Reviewed By Sunita Reddy

Annexure-3: Approval and Release Form

Date 18/06/2025
Material Name Thiocolchicoside
Qty Dispensed 100 g
Verified By (QA) Pravin Mehta
Status Approved

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial release New SOP QA Head
18/06/2025 2.0 Updated procedure and annexures Periodic Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Regulatory Impact of Missing SOPs for Deviation Management
Next Post: Biosimilars: SOP for Oxygen Mass Transfer Rate Determination – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version